Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000646EBVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS10013463HBVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS10006936HBVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS10001719HBVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS10011117HBVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS10023573HBVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS10029142HBVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS10035719HBVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS30080860HIVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS30082546HIVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TCGA Plot Options
Drug Information
GeneKCNJ6
DrugBank IDDB11633
Drug NameIsavuconazole
Target IDBE0001030
UniProt IDP48051
Regulation Typeinhibitor
PubMed IDs28074556
CitationsKeirns J, Desai A, Kowalski D, Lademacher C, Mujais S, Parker B, Schneidkraut MJ, Townsend R, Wojtkowski T, Yamazaki T, Yen M, Kowey PR: QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization. Clin Pharmacol Ther. 2017 Jun;101(6):782-790. doi: 10.1002/cpt.620. Epub 2017 Feb 13.
GroupsApproved; Investigational
Direct ClassificationPhenylpropanes
SMILESC[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Pathways
PharmGKB
ChEMBLCHEMBL409153